Richard Stern is a patent agent in the firm’s Intellectual Property practice group. With an extensive background in animal science, genetics and molecular and microbiology, he leverages his scientific acumen to guide clients in protecting their innovations and inventions.
He has experience writing, filing and prosecuting U.S. and foreign patent applications in areas including viral and pseudoviral vaccines, gene therapy, cancer immunotherapy, SNP-based phenotyping, stem cell production, pharmaceuticals, therapeutic and diagnostic devices and methods, and others. He is skilled at conducting patentability and freedom-to-operate searches, advising clients on filing strategies to optimize the value of their IP investment, monitoring competitors’ patent activity, and assisting litigation teams in discovery.
Further, Richard has past experience in-house for a manufacturer in the animal science field, where he managed a portfolio of more than 200 patents and related applications.
Prior to joining Armstrong Teasdale, Richard was a senior patent agent at another Denver area firm. Before that, he worked in-house at a manufacturer of veterinary diagnostic products, vaccines and pharmaceuticals.
- University of Florida (Ph.D., 1996)
- Molecular Genetics and Microbiology
- University of Massachusetts (B.S., cum laude, 1986)
- Animal Science
- U.S. Patent and Trademark Office
- American Intellectual Property Law Association (Member)
Charitable and Civic Involvement
- VHL Alliance